Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NovaBay Pharmaceuticals (NBY) Goodwill (2021 - 2023)

NovaBay Pharmaceuticals (NBY) has disclosed Goodwill for 3 consecutive years, with $348000.0 as the latest value for Q3 2023.

  • On a quarterly basis, Goodwill fell 92.27% to $348000.0 in Q3 2023 year-over-year; TTM through Sep 2023 was $348000.0, a 92.27% decrease, with the full-year FY2022 number at $348000.0, down 92.31% from a year prior.
  • Goodwill was $348000.0 for Q3 2023 at NovaBay Pharmaceuticals, roughly flat from $348000.0 in the prior quarter.
  • In the past five years, Goodwill ranged from a high of $4.5 million in Q4 2021 to a low of $348000.0 in Q4 2022.
  • A 3-year average of $2.4 million and a median of $2.4 million in 2022 define the central range for Goodwill.
  • Peak YoY movement for Goodwill: crashed 92.31% in 2022, then plummeted 92.27% in 2023.
  • NovaBay Pharmaceuticals' Goodwill stood at $4.5 million in 2021, then plummeted by 92.31% to $348000.0 in 2022, then changed by 0.0% to $348000.0 in 2023.
  • Per Business Quant, the three most recent readings for NBY's Goodwill are $348000.0 (Q3 2023), $348000.0 (Q2 2023), and $348000.0 (Q1 2023).